Angioplasty with stent in renal artery stenosis: our experience
|
|
- Rosemary York
- 6 years ago
- Views:
Transcription
1 Rev Chil Radiol 2016; 22(1): Angioplasty with stent in renal artery stenosis: our experience Johanna Marcela Vasquez Veloza *, José Luis Abades Vázquez, José Luis Cordero Castro. Interventional Radiology, San Pedro of La Rioja Hospital, Logrono, Spain. Abstract In this study we provide the results and effectiveness of angioplasty with stent in patients with renal artery stenosis who presented as well with a poorly controlled or refractory hypertension and renal failure. Retrospective study including 16 patients treated by angioplasty with stent. Blood pressure and renal function was monitored in the first 24 hr, 6 month and 12 month follow-ups after angioplasty. Reduction of systolic blood pressure from170 mm Hg to 145 mm Hg was achieved n the first 24 hrs, and to 138 mm Hg in the control at 12 months; the diastolic blood pressure increased from 95 mm Hg to 77 mm Hg in the first 24 hrs, and to 70 mm Hg in the control at 12 months. Renal function remained stable. Keywords: Renal artery stenosis; Angioplasty; Stent Introduction Renal artery stenosis (RAS) is a disease that in 90% of cases is secondary to atherosclerosis, affecting the ostium (80-85%) (Figure 1) or the proximal third of the renal artery (Figure 2). Figure 1 A selective aortogram and arteriography of the right renal artery was performed via the left femoral artery, with significant stenosis of the ostium being visible. Figure 2 Selective aortogram and arteriography of left renal artery is performed via the right femoral artery, with stenosis approximately 1 cm distal to the ostium being visible. The stenosis causes a reduction of 50% in the diameter of the artery and 75% of the area thereof. Its prevalence increases with age, especially in subjects with morbidity and mortality associated factors, such as diabetes mellitus (DM), the aortoiliac occlusive disease, arterial hypertension (high blood pressure - HBP) or heart disease. Progression is from 50% in the following 5 years after diagnosis, with occlusion from 3% to 16% and renal atrophy in 21% of the patients with stenosis greater than 60% (1). Stenosis of the renal artery can cause chronic renal failure if it affects both renal arteries, or if the hypertension associated with this condition is prolonged or critical. This can be serious in cases where it is accompanied with HBP, and sometimes accelerated or malignant, but often it is indistinguishable from essential HBP (1). As for the diagnosis of renal artery stenosis, Doppler ultrasound is the first screening test (2), as it allows for the identification of subclinical atheromatosis in the different vascular territories, renal disorders and renal artery stenosis (3), allowing for the evaluation of the increase of peak systolic velocity above 180 cm/s, being a good parameter to detect a stenosis greater than 60% (4-11). Another parameter used is the resistance index >0.8, allowing for the identification of the patients in whom revascularization will not improve kidney function, blood pressure or kidney survival (3,4). But it must be taken into account that it is Received 5th February 2016; accepted 25th February Available on internet 5th April * Author for correspondence. address: jmache@gmail.com (J.M. Vasquez Veloza) SOCHRADI. Published by Elsevier Spain, S.L.U. This is an Open Access article under license CC BY-NC-ND ( 13
2 J.M. Vasquez Veloza et al. operator-dependent, and in some cases can be difficult to evaluate, such as in obese patients or those with abundant intestinal gas, and it also does not allow for evaluation of the accessory renal arteries (5). Magnetic resonance angiogram and CT angiography are methods with high a sensitivity and specificity (more than 90%), used when the creatinine clearance exceeds 30 ml/min and 60 ml/min, respectively. Their main disadvantages are based on the limited capacity they have to objectify lesions that are not in the ostium, lesions of the accessory arteries and the respiratory or peristaltic artifacts (6). Renal angiography is used in patients with inconclusive imaging studies, in renovascular hypertension and renal failure due to renal artery stenosis (7). Contraindications are uncorrectable coagulopathy, proven allergy to iodinated contrast and bad vascular access. With this technique, data for the severity of the arterial stenosis and commitment of its branches can be obtained, in order to determine the best revascularization strategy. Even so, this technique is not without risk and may even worsen renal function, especially in diabetic patients or those who previously had an impaired renal function (8). Treatment of RAS helps to improve or in some cases cure hypertension and regulates renal function. However, its invasive treatment consists of 2 procedures: surgery and angioplasty. Surgical repair used primarily in patients who want to correct at the same time an aortic aneurysm, has a preoperative mortality from 2.1% to 6.1% when bypasses are implanted, and 4.7% when endarterectomy is performed. Reoperation at 5 years is from 5% to 15% in treated patients, and the survival rate is from 65% to 81% (9). Percutaneous angioplasty with stenting is a safe procedure, with low morbidity and high success rate in selected patients, as inpatient mortality is 0.5%, but the rate of restenosis remains a disadvantage, because it presents values between 11% to 23% at 5 years (7,8). The aim of this study is to verify the effectiveness of angioplasty with stenting as a treatment for renal artery stenosis using the results obtained in our institution. Materials and methods Study of retrospective case series, in which all patients diagnosed with significant and critical renal artery stenosis, operated between the 30th april 2007 to 30th april 2015 with angioplasty and stent implantation were included, yielding a population target of 16 patients in total. Patients had renal ultrasound with doppler, where renal artery stenosis was confirmed by the aforementioned parameters. Not all of the ultrasound reports had renal measurements, so that criterion is not taken into account in the study. Rev Chil Radiol 2016; 22(1): All of the patients underwent renal arteriography for correct diagnosis and to assess the degree of stenosis, considered significant when occlusion of the vessel lumen was between 50% to 80%, and critical when it was greater than 80% (Figure 3). Figure 3 A. Selective aortogram and arteriography of the right renal artery was performed via the left femoral artery, objectifying critical stenosis of the proximal third with ostium integrity. The left renal artery has early bifurcation with no signs of stenosis. B. After the infusion of 5000 IU heparin the 5 20 mm metal prosthesis is implanted with a satisfactory angiographic result. To perform the procedure, all patients received hydration protocol such as nephroprotective. It was performed via the femoral artery under local anaesthesia. Immediately, 5,000 IU of heparin was administered intravenously prior to the start of the intervention. Nonionic contrast medium was used during angioplasty. Subsequently patients received 75 mg of clopidogrel for a month and 100 mg acetylsalicylic acid for life. Angiographically diagnosed lesions were classified as ostial type lesion, those which are located in the first 5 mm into the main artery, and as not ostial lesion those found after the first 5 mm of the main artery. Herculink stents were used in 100% of the cases, most patients with a diameter of 6 mm and longitude of 20 mm (Table 1). After the angioplasty was performed renal function was assessed via plasma creatinine levels during their hospital stay. Hypertension stage was evaluated according to the classification by the National Committee of the United States, where a systolic blood pressure (SBP) less than 120 mm Hg and a diastolic blood pressure (DBP) of less than 80 mm Hg is defined as normotensive, SBP between mm Hg or DBP between mm Hg is defined as pre-hypertension, SBP between 14
3 Rev Chil Radiol 2016; 22(1): Table 1. Characteristics of the renal angioplasty stent Herculink Stent 17 Diameter 5 mm 8 (47%) 6 mm 9 (53%) Length 18 mm 4 (23%) 20 mm 12 (71%) 22 mm 1 (6%) obesity in 2 patients (12%) were taken into consideration. The majority of the patients were in functional class I, and mean serum creatinine was 1.83 mg/dl. No patient had previously been treated for renal angioplasty with stent. Fourteen patients were taking antihypertensive medication of different classes including diuretics, with an average of 2 drugs per patient (Table 2). Ten patients (62%) had significant renal artery stenosis (Figure 4) and 6 patients (38%) critical stenosis; 13 patients (81%) presented unilateral lesion, one with 2 ipsilateral renal arteries and 3 patients (19%) bilateral (Figure 4), with greater commitment of the right side mm Hg or DBP between mm Hg is hypertension stage I and SBP greater than 160 mm Hg or DBP greater than 100 mm Hg is hypertension stage II (10), resistant hypertension refers to patients taking 3 or more antihypertensive drugs of different classes, one of which is a diuretic, without being able to control blood pressure. Hypertension is considered cured when the SBP is reduced below 140 mm Hg and the DBP below 90 mm Hg after angioplasty, without the need to continue with antihypertensive drugs, and controlled hypertension when SBP is reduced below 140 mm Hg and DBP below 90 mm Hg with the decrease in the number of antihypertensive medications. A comparison of serum creatinine values before angioplasty and in the first 24 hrs and at 12 months after angioplasty was performed, considering deterioration of renal function when the serum creatinine increased to a value equal to or greater than 0.5 mg/dl, and improvement of same when a reduction occurs of serum creatinine equal to or greater than 0.5 mg/dl (12). Results Population 16 patients diagnosed with stenosis of more than 50% of the renal artery, aged between years; average 69 years, mostly male gender (56%), were included. Fourteen patients (87%) had a diagnosis of hypertension, the average SBP was 160 mm Hg and DBP of 90 mm Hg, of which 8 patients (57%) were diagnosed with resistant hypertension. All patients were admitted in the course of 30 days prior to renal angiography-angioplasty with stenting because of: hypertensive crisis in 5 patients (31%), deteriorated renal failure in 8 patients (50%) and AHT crisis with deteriorated renal failure in 3 patients (19%), one being diagnosed with de novo hypertension in this hospital stay. Risk factors for coronary heart disease such as type 2 diabetes in 6 patients (37%), dyslipidemia in 9 patients (56%), smoking in 4 patients (25%) and Table 2. Risk factors. Characteristics Age years, with an average of 69 Gender Female 7 Male 9 Blood Pressure figures Peak systolic blood pressure Average systolic blood pressure Peak diastolic blood pressure Average diastolic blood pressure 200 mm Hg 170 mm Hg 110 mm Hg 95 mm Hg Reason for admission AHT Crisis 5 AHT Crisis with deteriorated renal failure 3 Deteriorated renal failure 8 Arterial Hypertension De novo 1 Suitable Control 5 Poor Control 1 Resistant 8 Diabetes mellitus 6 Dyslipidemia 9 Obesity 2 Smoking 4 Ischemic history 1 (TIA) Creatinine Media high rates Low Maximum 1.83 mg/dl 0.9 mg/dl 4.26 mg/dl Number of antihypertensive drugs
4 J.M. Vasquez Veloza et al. Rev Chil Radiol 2016; 22(1): Figure 4. Bilateral renal arteriography is performed via the right femoral artery. Stenosis of more than 50% in the proximal third of the right renal artery can be seen, so implantation of 6 20 mm metal stent is decided with a satisfactory angiographic result. Critical stenosis is observed in the middle third of the left renal artery, which presents an ulcerated appearance, after pre-dilatation with 4 20 mm balloon catheter implantation of metal prostheses of 5 20 mm diameter is decided, with a satisfactory angiographic result. The angiographic characteristics were of atherosclerotic stenoses, being ostial type lesions in 5 patients (31%) and in 11 patients (69%) non ostial type; 4 patients (36%) with lesions to 1 cm of the ostium and 7 patients (64%) in its proximal third (Table 3). Table 3. Pre-angioplasty vascular characteristics. Variables Left artery 10 Right artery 9 Unilateral 13 Bilateral 3 Assessory 1 Ostium 5 To 1 cm from its source 4 Proximal third 7 Stenosis > 80% % 10 Procedure Of the 20 arterial commitments only 2 balloon pre-dilatations were performed, for critical stenosis that made passage of the catheter difficult. 17 stents (85%) were implanted. The other three stents were not implanted because: in one patient with bilateral commitment, a sufficient selective catheterization for the placement thereof in one side, was not obtained; in the other patient, who presented two ipsilateral renal arteries, access to the upper polar artery is attempted, succeeding on several occasions, but when the time comes to pass the guide catheter to proceed to place the stent it comes out repeatedly, failing to implant safely, so it is removed; in any case the repeated passage of material through the lesion causes an angioplasty effect on it, reducing its stenosis; the last patient only allowed the placement of a stent, although the stenosis was bilateral (such drawbacks were taken into account when collecting data). As a complication, hematoma at the puncture site which completely remitted after local management, was reported in only one patient (Table 4). The average hospital stay was 3 days. Table 4. Post-angioplasty variables. Immediate Immediate complications Inguinal hematoma 1 During the first 24 hrs of the hospital stay Blood pressure figures Peak systolic blood pressure 170 mm Hg Average systolic blood pressure 145 mm Hg Peak diastolic blood pressure 99 mm Hg Average diastolic blood pressure 77 mm Hg Creatinine Average 1.7 mg / dl Minimum 0.9 mg / dl Maximum 3.5 mg / dl Control at 12 months Average blood pressure figures Peak systolic blood pressure Average systolic blood pressure Peak diastolic blood pressure Average diastolic blood pressure Creatinine Average Minimum 145 mm Hg 138 mm Hg 80 mm Hg 70 mm Hg 1.68 mg / dl 1 mg / dl Maximum 3 mg / dl Number of antihypertensive drugs Improvement of renal function 3 No change in renal function 10 Deterioration of renal function 3 16
5 Rev Chil Radiol 2016; 22(1): Evolution of blood pressure During the first 24 hours of hospital stay in the 5 hypertensive patients the average SBP was 145 mm Hg with a maximum of 170 mm Hg, and the mean DBP was 77 mm Hg with a maximum of 90 mm Hg, with normal blood pressure values in 6 patients (37%) (Table 4). The patient that was not hypertensive presented no change in their blood pressure readings. Controls at 6 months post-angioplasty were performed with pressure values for SBP with maximum of 150 mm Hg and DBP with maximum of 80 mm Hg. The controls at 12 months post-angioplasty showed pressure values for SBP with average of 138 mm Hg and maximum of 145 mm Hg, and the DBP average was 70 mm Hg with a maximum of 80 mm Hg, these being statistically significant compared to the preangioplasty blood pressure readings (Table 4). The average number of antihypertensive drugs post-angioplasty was one per patient (Table 4). Evolution of renal function In relation to the creatinine in the control at 24 hrs, an average value of 1.7 mg/dl, with a minimum figure of 0.9 and a maximum of 3.5 was found; in the control at 12 months post-angioplasty an average value of 1.68 mg/dl was found; significant improvement in renal function in 3 patients (19%), with improved nonsignificant renal function in 10 patients (62%) and deteriorated renal function in 3 patients (19%) (Table 4). In the patient who was not hypertensive the indication for angioplasty was renal failure secondary to renal artery stenosis, showing improvement in serum creatinine figures at 24 hrs, and at 6 months and 12 months post-angioplasty. Other information 2 deaths occurred in the course of months post-angioplasty due to complications of kidney disease (Table 4). No reoperation was performed. Discussion Arterial hypertension is a public health problem that causes multiple organ failure and primary mortality, most often being secondary to the RAS, occurring in up to 5% of hypertensive patients5. RAS is associated with kidney failure, its treatment being in 14% to 20% of patients on dialysis. 6% is associated with end stage nephropathy, a high-risk disease as it has high mortality in the first 3 years after diagnosis (7). Angioplasty with stent is a very controversial procedure, therefore different complementary parameters (angiographic renal blush, fractional flow reserve and doppler resistance rate) are still being evaluated in order to identify the patients who could obtain the greatest clinical benefit, because it does not cure hypertension or renal failure, but helps control both disease processes, either by decreased use of drugs or adequate control of creatinine figures (11). However, current scientific evidence is insufficient to standardize the role of renal angioplasty (12). The latest and largest studies made (ASTRAL and CORAL) concluded that percutaneous intervention with stent placement for handling RAS had no benefits on the control of blood pressure or renal function (basing the latter on the serum creatinine value), but the results are taken as false positives because the tests are biased, either by error in the target population, for the stage of renal failure and for the extent of the same stenosis (in the ASTRAL study: 41% of patients have stenosis <70% of the renal artery, and the CORAL study 55% of patients have stenosis <70% of the renal artery and 50% of the cohort did not present renal failure or did in stage I or II) (13-15). We, in this study that we conducted in 16 patients, 15 hypertensive, all with significant or critical RAS, diagnosed with angiography and treated by angioplasty and stenting, have obtained favourable results for the treatment of hypertension stabilizing their numbers and achieving a better control of same with fewer antihypertensive drugs. Even so, no cure for hypertension was observed. As for serum creatinine numbers, an improvement in statistically nonsignificant renal function was found, providing a stability to that disease. From these results we consider treatment of RAS with angioplasty and stent implantation, as it allows systemic blood pressure improvement and control and stabilizes renal function in patients who have clear indications to undertake this procedure. Conclusion RAS is a disease with great impact in our midst, mainly for causing hypertension and nephropathy. Treatment with angioplasty and stenting is a therapeutic alternative that helps to control blood pressure and stabilize renal failure in patients with significant renal artery stenosis, resistant or poorly controlled hypertension and rapid deterioration of renal function. Conflict of interests The authors declare no conflict of interest. Bibliography 1. Armario P, Oliveras A. Estenosis de arteria renal, hipertensión arterial y nefropatía isquémica. Clin Invest Arterioscl. 2003; 15: ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, et al. Revascularization versus medical therapy for renalartery stenosis. N Engl J Med. 2009; 361: Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial. Hipertens Riesgo Vasc. 2013; 30 Supl 3:1. 17
6 J.M. Vasquez Veloza et al. 4. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 32: Orias M, Angioplastia renal en hipertensión, virtudes y defectos. XX congreso argentino de hipertensión arterial. En: Comunicación oral Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, et al. AHA Councils on Cardiovascular Radiology, High Blood Pressure Research, Kidney in Cardiovascular Disease, CardioThoracic and Vascular Surgery, and Clinical Cardiology, and the Society of Interventional Radiology FDA Device Forum Committee. American Heart Association. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 2002; 106: Safian D, Textor S. Renal artery stenosis. N Engl J Med 2001; 344: Corriere MA, Edwards MS, Pearce JD, Andrews JS, Geary RL, Hansen KJ. Restenosis after renal artery angioplasty and stenting: Incidence and risk factors. J Vasc Surg 2009; 50: Rundback JH, Sacks D, Craig K, Cooper C, Jones D, Murphy T, et al. Guidelines for the reporting of renal Rev Chil Radiol 2016; 22(1): artery revascularization in clinical trials. J Vasc Interventional Radiol 2003; 14: Sánchez R, Ayala M, Baglivo H, Velázquez C, Burlando G, Kohlmann O, et al. Guías latinoamericanas de hipertensión arterial. Rev Chil Cardiol 2010; 29: Lao D, Parasher P, Cho K, Yeghiazarians Y. Atherosclerotic renal artery stenosis-diagnosis and treatment. Mayo Clin Proc 2011; 86: Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med 2006; 145: Mohan IV, Bourke V. The management ofrenal artery stenosis: An alternative interpretation of ASTRAL and CORAL. ESVS Journal 2015; 49: Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial. Ann Intern Med 2009; 150: Mistry S, Ives N, Harding J, Fitzpatrick-Ellis K, Lipkin G, Kalra PA, et al. Angioplasty and stent for renal artery lesions (ASTRAL trial): Rationale, methods and results so far. J Hum Hypertens 2007; 21:
RAS Epidemiology. Renal Artery Stenosis. Pathophysiology of RAS. Disclosure of Potential Conflicts. Background Pathophysiology of RAS.
Renal Artery Stenosis RAS Epidemiology Common Disease Incidence General Population 0.1% Hypertensive Population 4% HTN & Suspected CAD 10-20% Malignant HTN 20-30% Malignant HTN and CKD 30-40% Alexander
More informationDisclosure of Potential Conflicts. Renal Artery Stenosis. RAS Epidemiology. Road Map. Background. ASDIN 7th Annual Scientific Meeting
Renal Artery Stenosis Disclosure of Potential Conflicts Cytopherx, Inc. R4 Vascular, Inc. Bard Peripheral Vascular Spectranetics, Inc. Alexander S. Yevzlin, MD Associate Professor of Medicine (CHS) ASDIN
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationEffective Health Care
Number 5 Effective Health Care Comparative Effectiveness of Management Strategies for Renal Artery Stenosis Executive Summary Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen
More informationA Closer Look: Renal Artery Stenosis. Renal artery stenosis (RAS) is defined as a TOPICS FROM CHEP. Shawn s stenosis
TOPICS FROM CHEP A Closer Look: Renal Artery Stenosis On behalf of the Canadian Hypertension Education Program (CHEP), Dr. Tobe gives an overview of renal artery stenosis, including the prevalence, screening
More informationRenal artery stenosis
Renal artery stenosis Dr. Alexander Woywodt Consultant Renal Physician, Royal Preston Hospital Preston, 31.10.2007 Menu anatomy of the renal arteries diseases of the large renal arteries atherosclerotic
More informationOutcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting
Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting Xue F Y, Bettmann M A, Langdon D R, Wivell W A Record Status
More informationRenal Artery Stenting
Renal Artery Stenting J.P. Reilly, MD, FSCAI Ochsner Medical Center Speaker s bureau: Astra Zeneca and Lilly/Diachi Sankyo Prevalence of RAS is high in cath population. Renal artery intervention can help
More informationLife After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention
Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention No Relationships to Disclose The Need for Modern Renal Trials Increased rate of RAS diagnosis
More informationRenal Artery Stenosis: Insights from the CORAL Trial
Renal Artery Stenosis: Insights from the CORAL Trial Christopher J. Cooper, M.D., FACC, FACP Dean and Senior Vice President University of Toledo, College of Medicine President, Ohio Chapter ACC State of
More informationHypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis
Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis
More informationPCI for Renal Artery stenosis
PCI for Renal Artery stenosis Why should we treat Renal Artery Stenosis? Natural History of RAS RAS is progressive disease Study Follow-up (months) Pts Progression N (%) Total occlusion Wollenweber Meaney
More informationRENAL ARTERY PTA. JH PEREGRIN IKEM, Prague
RENAL ARTERY PTA JH PEREGRIN IKEM, Prague PTRA/Stenting PTRA technical success rate > 90 % In some patients helps control hypertension In some patients can improve kidney function Serious complications
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationAtherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
Review ISSN 1738-5997 (Print) ISSN 2092-9935 (Online) Electrolyte Blood Press 8:87-91, 2010 doi: 10.5049/EBP.2010.8.2.87 Atherosclerotic Renovascular Hypertension : Lessons from Recent Clinical Studies
More informationDiagnosis of Renal Artery Stenosis (RAS)
May 2001 Diagnosis of Renal Artery Stenosis (RAS) Kurt Fink, Harvard Medical School, Year III Epidemiology Hypertension -Affects 60 million Americans Essential HTN >95% of cases Secondary HTN 1-5% of cases
More informationTreatment of renal artery in-stent restenosis with sirolimus-eluting stents
Treatment of renal artery in-stent restenosis with sirolimus-eluting stents Vascular Medicine 15(1) 3 7 The Author(s) 2009 Reprints and permission: http://www. sagepub.co.uk/journalspermission.nav DOI:
More informationFibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options
Fibromuscular Dysplasia (FMD) of the renal arteries Angiographic features and therapeutic options Poster No.: C-0630 Congress: ECR 2012 Type: Educational Exhibit Authors: K. I. Ringe, B. Meyer, F. Wacker,
More informationMasahiko Fujihara, MD
Verify the efficacy of renal artery stenting to define the predictive factors by physiological assessment with pressure wire gradient VERDICT study Masahiko Fujihara, MD Kishiwada Tokushukai Hospital Osaka,
More informationRenal Artery Stenting With Embolic Protection
Renal Artery Stenting With Embolic Protection Embolic protection during renal stenting may be beneficial, but new device designs are necessary. BY RAJESH M. DAVE, MD Renal artery stenosis (RAS) is the
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationRenal Artery FFR. Woo-Young Chung. Seoul National University, College of Medicine Boramae Medical Center Cardiovascular Center
Renal Artery FFR Woo-Young Chung Seoul National University, College of Medicine Boramae Medical Center Cardiovascular Center Why renal FFR? Renal artery angioplasty (PTRA) Indication of Renal artery angioplasty
More informationV.A. is a 62-year-old male who presents in referral
, LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.
More informationEndovascular treatment
210..217 NEPHROLOGY 2010; 15, S210 S217 doi:10.1111/j.1440-1797.2009.01243.x Endovascular treatment Date written: February 2009nep_1243 Final submission: August 2009 Authors: Robert MacGinley, Subramanian
More informationRenal Intervention. Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014
Renal Intervention Douglas E. Drachman, MD, FSCAI Division of Cardiology Vascular Medicine Section December 9, 2014 Disclosure Information Douglas E. Drachman, MD, FACC Abbott Vascular, Inc.: Advisory
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationCIC Edizioni Internazionali. original article
G Chir Vol. 36 - n. 4 - pp. 161-167 July-August 2015 The results of treatment in renal artery stenosis due to Takayasu disease: comparison between surgery, angioplasty, and stenting. A monocentrique retrospective
More informationEVAR replaced standard repair in most cases. Why?
EVAR replaced standard repair in most cases. Why? Initial major steps in endograft evolution Papazoglou O. Konstantinos M.D. The story of a major breakthrough in vascular surgery 1991 Parodi introduces
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationCORAL Trial Aftermath: What Do We Do Now? Renal Revascularization in Perspective
CORAL Trial Aftermath: What Do We Do Now? Renal Revascularization in Perspective Michael R. Jaff, DO Massachusetts General Hospital Boston, Massachusetts, USA Michael R. Jaff, DO Conflicts of Interest
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant INDICATION: Abdominal aortic aneurysm. INTERVENTIONAL RADIOLOGIST:
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationComparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)
Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of November 19, 2018 Abdominal Aortogram, Bilateral Runoff
More informationCoral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.
Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico
More informationCarotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA
Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:
More informationOstial Stents and Distal Embolic Protection During Renal Stenting
Ostial Stents and Distal Embolic Protection During Renal Stenting John R. Laird, MD Professor of Medicine Director of the Vascular Center UC Davis Medical Center Limitations of Current Techniques of Renal
More informationOriginal paper. Introduction. treatment of atherosclerotic RAS is controversial. Percutaneous
Original paper Clinical outcomes and effectiveness of renal artery stenting in patients with critical atherosclerotic renal artery stenosis: does it improve blood control and renal function assessed by
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationSubclavian artery Stenting
Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence
More informationORIGINAL ARTICLE. Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian Medical University, Katowice, Poland
ORIGINAL ARTICLE Cardiology Journal 2009, Vol. 16, No. 6, pp. 514 520 Copyright 2009 Via Medica ISSN 1897 5593 Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with
More informationNYU School of Medicine Department of Radiology Rotation-Specific House Staff Evaluation
Vascular & Interventional Radiology Rotation 1 Core competency in vascular and interventional radiology during the first resident rotation consists of clinical objectives, technical objectives and image
More informationCAROTID ARTERY ANGIOPLASTY
CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline
More informationRadiologic Evaluation of Peripheral Arterial Disease
January 2003 Radiologic Evaluation of Peripheral Arterial Disease Grace Tye, Harvard Medical School Year III Patient D.M. CC: 44 y/o male with pain in his buttocks Occurs after walking 2 blocks. Pain is
More informationNatural history and progression of atherosclerotic renal vascular stenosis
204..209 NEPHROLOGY 2010; 15, S204 S209 doi:10.1111/j.1440-1797.2009.01242.x Natural history and progression of atherosclerotic renal vascular stenosis Date written: December 2008nep_1242 Final submission:
More informationVascular Imaging Original Research
MDCT Angiography of Renal Arteries Vascular Imaging Original Research Adam D. Talenfeld 1 Ryan B. Schwope Huntley J. Alper Emil I. Cohen Robert A. Lookstein Talenfeld AD, Schwope RB, Alper HJ, Cohen EI,
More informationFor Personal Use. Copyright HMP 2013
Case Report J INVASIVE CARDIOL 2013;25(2):E39-E41 A Case With Successful Retrograde Stent Delivery via AC Branch for Tortuous Right Coronary Artery Yoshiki Uehara, MD, PhD, Mitsuyuki Shimizu, MD, PhD,
More information2017 Cardiology Survival Guide
2017 Cardiology Survival Guide Chapter 2: Angioplasty/Atherectomy/Stent The term angioplasty literally means "blood vessel repair." During an angioplasty procedure, the physician inserts a catheter, with
More informationAn Overview of Post-EVAR Endoleaks: Imaging Findings and Management. Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC
An Overview of Post-EVAR Endoleaks: Imaging Findings and Management Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC Disclosure Slide Mark O. Baerlocher: Current: Consultant for Boston
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationIncidence and Prevalence of Atherosclerotic Renal Artery Stenosis (RAS) in Patients with Coronary Artery Disease (CAD)
Incidence and Prevalence of Atherosclerotic Renal Artery Stenosis (RAS) in Patients with Coronary Artery Disease (CAD) AHMW Islam, S Munwar, S Talukder, AQM Reza Dept. of Invasive & Interventional Cardiology,
More informationAppropriate Patient Identification For Renal Artery Intervention Remains Challenging
Renal Intervention Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM Director, Interventional Cardiology, Cardiovascular Institute Director, Cardiac Cath Labs, Rhode Island &The Miriam Hospitals None Disclosures
More informationParaplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria
Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy Johannes Lammer Medical University Vienna, Austria Conflict of interests: none 68y, male, PAU in coral reef aorta,
More informationSuccessful percutaneous treatment of late-onset femoral pseudoaneurysm after transcatheter, aortic valve implantation procedure
Case Report Page 1 of 5 Successful percutaneous treatment of late-onset femoral pseudoaneurysm after transcatheter, aortic valve implantation procedure Murat Celik, Uygar Cagdas Yuksel Correspondence to:
More informationHidden coronary disease in carotid patients
6 th ACST-2 Collaborators Meeting in Valencia, Spain 24th and 25th September 2018 Hidden coronary disease in carotid patients Valerio Tolva Policlinico di Monza Italy Are we always aware of coronary anatomy?
More informationIVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC
IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for
More informationThe European Consensus on Fibromuscular Dysplasia
The European Consensus on Fibromuscular Dysplasia Alexandre Persu, M.D.-PhD Cardiology Department Cliniques Universitaires Saint-Luc Catholic University of Louvain Brussels, Belgium Eur J Clin Invest.
More informationShould Mesenteric Revascularization Be Staged: Report of 3 Cases One With Reperfusion Hemorrhage
Should Mesenteric Revascularization Be Staged: Report of 3 Cases One With Reperfusion Hemorrhage Ayhan Olcay MD 1, Kivanc Yalin MD 1, Sukriye Ebru Golcuk MD 1, Sukru Sanli MD 2 1. Bayrampasa Kolan Hospital,
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationTOBA II 12-Month Results Tack Optimized Balloon Angioplasty
TOBA II 12-Month Results Tack Optimized Balloon Angioplasty William Gray, MD System Chief, Cardiovascular Division Main Line Health, Philadelphia, PA Dissection: The Primary Mechanism of Angioplasty Lesions
More informationPredicting blood pressure response after renal artery stenting
From the Southern Association for Vascular Surgery Predicting blood pressure response after renal artery stenting Adam W. Beck, MD, a Brian W. Nolan, MD, a,b Randall De Martino, MD, a Theodore H. Yuo,
More informationA randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial
A randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial (TECCO randomized clinical trial, NCT01353651) Y. Gouëffic, N. Della Schiava,
More informationRenal Artery Stenosis With Severe Hypertension: A Case Report
CASE REPORT Renal Artery Stenosis With Severe Hypertension: A Case Report Suwaid MA ABSTRACT Background: Renal artery stenosis (RAS) is found in 77% of hypertensive patients and is responsible for 1-2%
More informationMultislice CTA for Renal Artery Stenting
Multislice CT for Renal rtery Stenting How CT can be a useful modality for diagnosing and managing renal artery stenosis for stent placement. Y MICHEL WHOLEY, MD, M; JMES WU, ; WILLIM C.L. WU, MD, FCC;
More informationVascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the
More informationIs Renal Artery Stenting Still Relevant? A Cohort Analysis
Is Renal Artery Stenting Still Relevant? A Cohort Analysis Sunil Naik, MD*, Brijesh Patel, DO, Anas Souqiyyeh, MD, Marc Zughaib, David Eastes, MPH, Marcel Zughaib, MD Abstract Atherosclerotic renal artery
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationCarotid Stenosis (carotid artery disease)
1 Carotid Stenosis (carotid artery disease) Overview Carotid stenosis is a narrowing of the carotid arteries, the two major arteries that carry oxygenrich blood from the heart to the brain. Also called
More informationCase Report Coronary Artery Perforation and Regrowth of a Side Branch Occluded by a Polytetrafluoroethylene-Covered Stent Implantation
International Scholarly Research Network Volume 2011, Article ID 212851, 4 pages doi:10.5402/2011/212851 Case Report Coronary Artery Perforation and Regrowth of a Side Branch Occluded by a Polytetrafluoroethylene-Covered
More informationEndovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease
Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND
More informationSurgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty
Surgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty Michel Lacombe, MD, a and Jean-Baptiste Ricco, MD, PhD, b Clichy and Poitiers, France
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of June 4, 2018 Thrombolysis, Thrombectomy & Angioplasty
More informationEvaluation of the Safety and Effectiveness of Renal Artery Stenting After Unsuccessful Balloon Angioplasty The ASPIRE-2 Study
Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.073
More informationAtherosclerotic Renal Artery Stenosis
Atherosclerotic Renal Artery Stenosis When is open surgical reconstruction the best treatment option? BY THOMAS A. ABBRUZZESE, MD, AND RICHARD P. CAMBRIA, MD Atherosclerotic disease is the most common
More informationav ailab le at jou rn al h om epa g e:
Journal of Cardiology Cases (2011) 4, e163 e167 av ailab le at www.sciencedirect.com jou rn al h om epa g e: www.elsevier.com/locate/jccase Case Report In vivo intravascular ultrasound imaging of fibromuscular
More informationThe Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography
Research imedpub Journals http://www.imedpub.com/ DOI: 10.21767/2572-5483.100036 Journal of Preventive Medicine The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography Andrew
More informationCPT Code Details
CPT Code 93572 Details Code Descriptor Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically
More informationUse of polytetrafluoroethylene renal bypass
Use of polytetrafluoroethylene renal bypass grafts for P. Lagneau, M.D., J. B. Michel, M.D., and J. M. Charrat, M.D., Paris, France Fifty-six revascularizations of the renal arteries were performed in
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationResearch Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden
ISRN Cardiology, Article ID 825461, 4 pages http://dx.doi.org/10.1155/2014/825461 Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationThe Centers for Medicare & Medicaid Services
Percutaneous Renal Revascularization and Medicare Coverage The Society of Interventional Radiology s position on the current CMS coverage of renal interventions. BY DAVID SACKS, MD, AND TIMOTHY P. MURPHY,
More informationCerebral hyperperfusion syndrome after carotid angioplasty
case report Cerebral hyperperfusion syndrome after carotid angioplasty Zoran Miloševič 1, Bojana Žvan 2, Marjan Zaletel 2, Miloš Šurlan 1 1 Institute of Radiology, 2 University Neurology Clinic, University
More informationChronic renal artery occlusion: Nephrectomy versus revascularization
ORIGINAL ARTICLES Chronic renal artery occlusion: Nephrectomy versus revascularization Timothy C. Oskin, MD, Kimberley J. Hansen, MD, Jonathan S. Deitch, MD, Timothy E. Craven, MSPH, and Richard H. Dean,
More informationSAMMPRIS. Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis. Khalil Zahra, M.D
SAMMPRIS Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis Khalil Zahra, M.D Major points Patients with recent TIA or stroke and intra-cranial artery
More informationPrevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation
Prevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation Marco Roffi Division of Cardiology University Hospital Geneva, Switzerland Disclosure Speaker name:...marco
More informationVivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither
More informationMichael Meuse, M.D. Vascular and Interventional Radiology
Michael Meuse, M.D. Vascular and Interventional Radiology Which patient would likely benefit from renal artery revascularization? Patient A- 60 y/o male with 20 year hx of htn; on 2 drug therapy for 10
More informationAbdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease
Eur J Vasc Endovasc Surg (2010) 39, 714e718 Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease G. Styczynski a, *, C. Szmigielski a, J. Leszczynski b, A. Kuch-Wocial a, M. Szulc a a
More informationDepartment of Internal Medicine, Saitama Citizens Medical Center, Saitama , Japan
Case Reports in Cardiology Volume 2016, Article ID 8790347, 5 pages http://dx.doi.org/10.1155/2016/8790347 Case Report GuideLiner Catheter Use for Percutaneous Intervention Involving Anomalous Origin of
More informationCase 8038 Renal allograft complicated with renal artery stenosis
Case 8038 Renal allograft complicated with renal artery stenosis Santiago I, Canelas A, Pinto AP Section: Cardiovascular Published: 2009, Nov. 30 Patient: 61 year(s), male Clinical History A 61-year-old
More informationVascular Access: Management of Complications. Chris Burrell, South West Cardiothoracic Centre, Plymouth
Vascular Access: Management of Complications Chris Burrell, South West Cardiothoracic Centre, Plymouth Alternative Vascular Access Sites Femoral Axillary Brachial Radial Ulnar Femoral v Radial Vascular
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationAssessment of recurrent mesenteric ischemia after stenting with a pressure wire
524852VMJ0010.1177/1358863X14524852Vascular MedicineMargiotta and Gray research-article2014 Case Report Assessment of recurrent mesenteric ischemia after stenting with a pressure wire Vascular Medicine
More informationRenal Artery Denervation New Concepts in Hypertension Treatment
Renal Artery Denervation New Concepts in Hypertension Treatment Istanbul Course of Interventional Cardiology J. Weil Medizinische Klinik II Kardiologie, Angiologie und internistische Intensivmedizin Universitätsklinikum,
More information